Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2174 (LINC02174) is a long non-coding RNA (lncRNA) belonging to the class of long intergenic non-coding RNAs (lincRNAs). LincRNAs are autonomously transcribed, non-coding transcripts longer than 200 nucleotides that do not overlap protein-coding regions[1][5]. They are recognized for contributing to gene regulation, chromatin architecture, transcriptional control, and RNA metabolism, often displaying tissue specificity and regulatory versatility[1][3][5]. Most lincRNAs, including LINC02174, have not been functionally characterized in detail, and specific roles in physiology or disease for LINC02174 have not been established in the literature. LincRNAs represent an emergent area of genomic regulation. While the most prominent lincRNAs (like XIST or HOTAIR) are well-studied and involved in key processes such as X-chromosome inactivation or development, the vast majority, including LINC02174, await further biological and clinical characterization[1][3][5].
None known (no drugs directly targeting LINC02174 have been identified)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2174 (LINC02174).